Our Field Chief Editor, Prof. Cecilia Giulivi, is currently out of the office and will return on 18th May 2025. If you have a query that you would like to raise to the Field Chief Editor, please contact Prof. Graça Soveral, Specialty Chief Editor for Cellular Biochemistry, or the Frontiers in Molecular Biosciences office (molecular.biosciences@frontiersin.org) instead and we will assist you.

Frontiers in Molecular Biosciences is a multidisciplinary journal focusing on understanding biological processes at the molecular level. It is currently indexed in the BIOSIS, SciFinder, Web of Science, Embase, DOAJ, SCIE, Scopus, and PubMed Central (PMC), among others.

The journal is led by Field Chief Editor Prof Cecilia Giulivi (University of California, Davis, US). The journal welcomes submissions in all areas of molecular bioscience research that illustrate the molecular mechanisms regulating the basic and applied metabolism of proteins, nucleic acids, carbohydrates, lipids, and metabolites in health and disease states, including aging, pharmacological interventions, and genetic and acquired diseases, among others.

Topics of interest include:

biological modeling and simulation
cellular biochemistry
genome organization and dynamics
glycoscience
lipids, membranes and, membranous organelles
metabolomics
molecular biophysics
molecular diagnostics and therapeutics
molecular evolution
molecular recognition
nanobiotechnology
protein biochemistry for basic, and applied sciences
RNA networks and biology
structural biology.

The Journal encompasses several empirical disciplines, including structural biology, enzymology, biochemistry, molecular biology, and biophysics. In addition to presenting novel discoveries, methodologies, and practical applications, Frontiers in Molecular Biosciences encourages the submission of testable hypotheses to inspire diverse perspectives and foster scientific discourse. Integrating in silico, in vitro, and in vivo approaches is particularly interesting.

Please note that this journal does not publish manuscripts solely focused on clinical oncology, cancer epidemiology, or cancer prognosis that lack a clear molecular mechanisms perspective within the biosciences. Likewise, studies that offer only descriptive accounts and do not provide mechanistic insights into the molecular underpinnings of biological processes fall outside the journal's scope.

Frontiers’ journals require that manuscripts primarily comprising computational studies of public data, must include appropriate validation. Please refer to the Frontiers Standards for research methodology policy, for more information. Manuscripts not adhering to these standards will not be considered.

Frontiers in Molecular Biosciences is dedicated to advancing molecular bioscience research by disseminating scientific knowledge to researchers and the general public, thus facilitating future breakthroughs in scientific understanding.

Impact

Frontiers in Molecular Biosciences

Molecular Diagnostics and Therapeutics